Detalhe da pesquisa
1.
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84).
J Clin Oncol
; 38(29): 3377-3387, 2020 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730183
2.
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.
J Clin Oncol
; 34(17): 2028-36, 2016 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27114593
3.
Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOP.
Hematology
; 18(1): 26-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22980138
4.
Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study.
Leuk Lymphoma
; 52(5): 796-803, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21338278